SNStaffan Normark

Staffan Normark

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Staffan Normark has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Humans: Intertwined with life and the basic elements in the Anthropocene biosphere

    by Carl Folke, Andrew Hattle, Peter Søgaard Jørgensen, Henrik Österblom, Tone Bjordam, Gregory Bratman, Connor Lashus, Staffan Normark, Lan Wang-Erlandsson, Gretchen Daily, et al.

    The notion of people and nature as intertwined and embedded in the biosphere is gaining traction in contemporary scientific discourses. But what does it mean for a human being to be intertwined? Here, we explore this question through two lenses: looking at the human body as an open living system in continuous exchange with the chemical elements on Earth; and looking across the biosphere, at the intricate functioning of the web of life in mediating these exchanges. The first lens focuses on relationships between chemical elements and life processes within us humans, relationships that are critical for our bodies to operate and function. We then expand the perspective to show how microorganisms, fungi, plants, and animals in ecosystems shape and mediate the elemental flows through the air, water, and food that our bodies require for survival. The two lenses highlight that humans have evolved as part of, and remain integrated with, these complex and dynamic life–element interdependencies, spanning all scales and domains across the biosphere. In the Anthropocene, humans remain as bodily dependent on life-mediated elemental cycles as ever, irrespective of culture, economic development, or technological advances. This inseparability reflects the core reality of existing in the biosphere, with implications for how to approach and understand human–environment relations and confront the challenges of the Anthropocene. It further implies that biosphere stewardship is not only a cognitive or ethical orientation, but also an embodied practice: one that involves learning about, caring for, and enhancing the living relations that mobilise, regenerate, and circulate life-sustaining elements.

  • Open Access

    Pneumococcal membrane particles promote serotype-independent cellular and humoral immunity and protect against pneumococcal colonization

    by Rebecca Dookie, Ana Rita Narciso, Meztlli O. Gaytán, Anandi Narayana Moorthy, Sayoni Chakraborty, Sigrun Thorsdottir, John Boss, Francesco Righetti, Jens Karlsson, Max Heurgren, et al.

    Despite implementation of pneumococcal conjugated vaccines (PCVs) against Streptococcus pneumoniae infections, these diseases are still major contributors to global mortality and morbidity, highlighting the need for a novel immunization strategy. Pneumococci release extracellular vesicles/membrane particles (MP) that are enriched in lipids, virulence factors, and surface proteins, and show great efficacy in protecting against invasive pneumococcal disease in mice. As such, MP present an alternative vaccine strategy. However, an in-depth understanding of how pneumococcal MP interact and modulate the immune system in vivo is currently lacking. In this study, we demonstrate that pneumococcal MP possess robust intrinsic adjuvant properties and conserved antigens, including MalX and PrsA, that support a strong serotype-independent effector and memory Th17 response in mice and humans. Mechanistically, vesicles are sensed through TLR2 and signaling through this receptor is required for the human IL-17 response. Moreover, intranasal immunization with MP expands the tissue resident macrophage populations in the lungs with enhanced functional capacities. Our study also demonstrates that MP immunization in the absence of adjuvant is sufficient to protect against colonization in mice.


  • Open Access

    Identification of immunostimulatory antigens in Group A Streptococcus –derived vesicles

    by Meztlli O. Gaytán, Rebecca S. Dookie, Sayoni Chakraborty, Anandi Narayana Moorthy, Stefan Kreida, Anna Norrby-Teglund, John Boss, Max Heurgren, Staffan Normark, Birgitta Henriques-Normark

    An effective vaccine against Streptococcus pyogenes (Group A Streptococcus , GAS) is urgently needed. Bacteria-derived extracellular vesicles (EVs) are emerging as promising vaccine platforms. In this study, we evaluated the immunostimulatory properties of GAS-derived EVs when administered intranasally in mice. Immunization induced a strong humoral response, including pathogen-specific immunoglobulin G (IgG) and immunoglobulin A (IgA) antibodies. Additionally, we observed local and systemic T cell responses, specifically a robust Th17 response along with a modest but statistically significant Th1 response. Through immunoprecipitation coupled with mass spectrometry and western blotting, we identified seven immunogenic proteins, including the lipoproteins MtsA, BMP, PrsA1, PrsA2, MetQ, MalX, and the glutamine transporter GlnP. These antigens were recognized by human sera from both healthy individuals and patients with necrotizing soft tissue infection. Finally, we demonstrate that these antigens stimulate production and secretion of IL-17A by lung cells and splenocytes and that they are highly conserved across diverse GAS M-types, highlighting their potential as broadly protective vaccine candidates.

  • Open Access

    Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA

    by Ana Rita Narciso, Federico Iovino, Sigrun Thorsdottir, Peter Mellroth, Mario Codemo, Christian Spoerry, Francesco Righetti, Sandra Muschiol, Staffan Normark, Priyanka Nannapaneni, et al.

    Significance: Pneumococcal infections are major contributors to morbidity and mortality worldwide. Introduction of pneumococcal conjugated vaccines (PCVs) into the childhood vaccination program has led to a decrease in invasive pneumococcal disease (IPD) in vaccinated children but concurrently to an increase of nonvaccine-type IPD, also in nonvaccinated age groups such as the elderly. Thus, novel vaccine approaches are urgently needed, especially for the elderly, targeting all pneumococci causing IPD. Here, we show that pneumococcal membrane particles (MPs) evoke a serotype-independent cross-protection against IPD. This protection is dependent on the presence of the two conserved lipoproteins MalX and PrsA. We suggest that MPs can be used for pneumococcal vaccine development.


  • Open Access

    THCz: Small molecules with antimicrobial activity that block cell wall lipid intermediates

    by Elisabeth Reithuber, Torbjörn Wixe, Kevin C. Ludwig, Anna Müller, Hanna Uvell, Fabian Grein, Anders E. G. Lindgren, Sandra Muschiol, Priyanka Nannapaneni, Anna Eriksson, et al.

    Significance: Considering the alarming emergence of resistance to most antibiotics and the need for new antibiotics, the finding here of a small-molecule class, THCz, that displayed bactericidal activity against gram-positive and selected gram-negative bacteria, is of the greatest importance. We found that THCz target the cell envelope synthesis and can easily be synthesized and modified, and resistance did not readily develop in vitro. Thus, THCz are promising scaffolds for development of bacterial cell wall inhibitors.


  • Open Access

    Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways

    by Vicky Sender, Karina Hentrich, Anuj Pathak, Alicia Tan Qian Ler, Bethel Tesfai Embaie, Susanna L. Lundström, Massimiliano Gaetani, Jan Bergstrand, Rei Nakamoto, Lok-To Sham, et al.

    Significance: Mechanisms for why influenza A virus (IAV) infections sensitize for pneumococcal infections are not clear. Here, we show that IAV-induced capillary leakage results in influx of nutrients and antioxidants to the lungs, thereby promoting pneumococcal growth in the lower respiratory tract. The evoked inflammation leads to redox imbalances that require bacterial adaptation to the oxidized environment, including induction of the pneumococcal chaperone/protease HtrA that protects the bacteria from clearance by the immune system. The results give us insight into the delicate interplay between the bacteria and the host environment during coinfections that needs to be explored in order to find novel therapeutic approaches.


  • Structure, Function, and Biogenesis of Escherichia coli P Pili

    by Meta J. Kuehn, David Haslam, Staffan Normark, Scott J. Hultgren

    Bacterial adherence is an important early step in infection and results from the specific binding of a bacterial protein, called an adhesin, to a eukaryotic cell receptor. 1-3 The specificity of a particular adhesin for a particular glycolipid or glycoprotein receptor on epithelial cells is in part responsible for the tissue and host tropism of pathogenic bacteria. Adherence leads to the colonization of tissues by preventing bacteria from being cleared by the normal flow of bodily fluids. Infection, inflammation, and eventually, bacteremia can result from bacterial colonization. In many cases, bacterial adhesins are associated with rod-like structures called pili which radiate from the surface of bacteria. Pili are protein polymers composed of approximately a thousand copies of a major pilus subunit and several minor pilus subunits that play important roles in adhesion presentation, polymerization initiation, and termination.

  • Open Access

    The impact of the ancillary pilus‐1 protein RrgA of Streptococcus pneumoniae on colonization and disease

    by Federico Iovino, Priyanka Nannapaneni, Birgitta Henriques‐Normark, Staffan Normark

    The Gram‐positive bacterium Streptococcus pneumoniae, the pneumococcus, is an important commensal resident of the human nasopharynx. Carriage is usually asymptomatic, however, S. pneumoniae can become invasive and spread from the upper respiratory tract to the lungs causing pneumonia, and to other organs to cause severe diseases such as bacteremia and meningitis. Several pneumococcal proteins important for its disease‐causing capability have been described and many are expressed on the bacterial surface. The surface located pneumococcal type‐1 pilus has been associated with virulence and the inflammatory response, and it is present in 20%–30% of clinical isolates. Its tip protein RrgA has been shown to be a major adhesin to human cells and to promote invasion through the blood‐brain barrier. In this review we discuss recent findings of the impact of RrgA on bacterial colonization of the upper respiratory tract and on pneumococcal virulence, and use epidemiological data and genome‐mining to suggest trade‐off mechanisms potentially explaining the rather low prevalence of pilus‐1 expressing pneumococci in humans.


  • The rise of hyper‐virulence

    by Marie‐Stéphanie Aschtgen, Birgitta Henriques‐Normark, Staffan Normark

    Click here to view the Review by Weiss et al.